The NeuroCognitive & Behavioral Institute (formerly The NeuroCognitive Institute) is an active site of clinical trials for Neuropsychiatric Disorders. Clinical trials are the best way for researchers to find new ways to detect, slow, treat and hopefully someday prevent and cure these diseases.
NCI is currently enrolling volunteers for the following clinical trials.
Past Studies
- A Study of the Change in Disease State and Safety of Oral Cariprazine Capsules in the Treatment of Depression in Pediatric Participants With Bipolar I Disorder
- Phase III Ziprasidone Trial in Treating Cognitive Dysfunction in Schizophrenic Patients. SI: 2007-2008.
